Share this to:

Support & Insight for the Autumn of Life

Prescribing Lecanemab in Real Life

woman wearing yellow and pink floral dress wahing carrots
Dr. Robert Przybelski has prescribed lecanemab to real-life patients, and discusses his experience prescribing and administering the treatment. (Video)

On July 6, 2023, the U.S. Food and Drug Administration (FDA) granted full approval for the Alzheimer’s disease drug Leqembi (lecanemab-irmb), the first medicine shown to delay the course of the disease.

Having gone through a rigorous approval process, the medication exemplifies a critical advancement in the ongoing battle to treat Alzheimer’s disease.

Dr. Robert Przybelski, director of Geriatric Memory Clinics UW Health, profession of the Division of Geriatrics and Gerontology, University of Wisconsin School of Medicine and Public Health, has already prescribed the treatment to real-life patients.

Dr. Przybelski joins the podcast to discuss his experience prescribing and administering lecanemab, what clinicians and patients should discuss when considering these treatments, and what is needed to integrate these treatments into the healthcare system.


SOURCE:

Wisconsin Alzheimer’s Disease Research Center YouTube Channel

Subscribe
Notify of
guest

1 Comment
Inline Feedbacks
View all comments
R Eckroth
R Eckroth
July 31, 2023 6:31 pm

Great to be able to listen to the pod casts

Hanna Levi Julian

Hanna Levi Julian

Visit Our Pages On:

Welcome

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chaffe, the important articles & videos from each week’s river of news. With a new post on Alzheimer’s or dementia appearing on the internet every 7 minutes, the site’s focus on the best information has been a help to many over the past 15 years. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Related

Leqembi
Leqembi: An Alzheimer's Drug Worth Rooting For?
At long last, we finally have a disease-modifying drug for Alzheimer’s. The FDA recently approved a new drug that pro...
Agitated Woman in a White Shirt and Denim Pants Sitting on a Couch
Agitation in Alzheimer's: Rexulti® Makes Meaningful Improvements
In a new Alzheimer's study, Rexulti (brexpiprazole) significantly reduced agitation. Learn the kinds of agitation it ...
Photo Of Man Sitting On A PET Scanner
Amyloid PET Scan Coverage Approved at Last
Amyloid Scans diagnose and treat Alzheimer's, at a hefty price. 11 years after FDA approval, Medicare can finally help.
1
0
Would love your thoughts, please comment.x
()
x
News, Treatments, Care Tips

Subscribe To The Weekly Newsletter

videos & articles on Research & Prevention
News to Get at the Truth

Subscribe To Our Weekly Newsletter